Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Guangzhou Follisave Technology Development Ltd. is currently prosecuting a portfolio in the Medical Devices & Mechanical Engineering technology area. There is 1 pending office action active at this time. This single matter is the current focus of the applicant's engagement with the patent office.
The prosecution is concentrated under 1 distinct examiner and 1 distinct art unit. This indicates that the technical subject matter is specialized and has not been diverted to other examination groups. For a practitioner, this means there is no requirement to navigate different art unit policies or multiple examiner temperaments.
RAUBENSTRAW, TYLER ALLEN is the busiest examiner for this portfolio, managing 1 busiest examiner pending office action. Since the total count of pending office actions is 1, this examiner is responsible for the entire active workload. The practitioner should focus on the specific tendencies and prior decisions of this individual.
With 1 distinct examiner and 1 distinct art unit, the prosecution process is highly centralized. The practitioner can manage the 1 pending office action with a clear understanding of the single examiner's expectations. This streamlined structure reduces the administrative burden of tracking multiple disparate patent applications.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAUBENSTRAW, TYLER ALLEN | 1 | 71.2% | +30.6% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18003065 | VASOCOMPRESSION DEVICES AND METHODS OF DELIVERING VASOCOMPRESSION THERAPY TO A PATIENT UNDERGOING CHEMOTHERAPY TREATMENT | RAUBENSTRAW, TYLER ALLEN | — |
| Art Unit | Apps |
|---|---|
| 3785 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18003065 | VASOCOMPRESSION DEVICES AND METHODS OF DELIVERING VASOCOMPRESSION THERAPY TO A PATIENT UNDERGOING CHEMOTHERAPY TREATMENT | RAUBENSTRAW, TYLER ALLEN | 3785 | §103 | Final Rejection | — | Pending | Dec 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGuangzhou Follisave Technology Development Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Tyler Allen Raubenstraw has the most, with 1 of Guangzhou Follisave Technology Development Ltd.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
